Federal award
QIAGEN, LLC
N0025917F0288
Contract
Obligated and Ceiling
- Obligated (net)
- $90,102.48
- Ceiling (potential value, not spending)
- $90,102.48
- Current value
- $90,102.48
- Gross positive obligations
- $126,476.34
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- QIAGEN, LLC · W2GLKC92ZH73
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- QIAGEN N.V. · LX8AGV4A2UD1
- Awarding agency
- Department of War · sub-agency 1700 · office N00259
- Funding agency
- Department of War · sub-agency 1700
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- N0025917F0288
- Parent vehicle (IDV PIID)
- V797P5271B
- Award type code
- C
- Actions
- 3 · Sep 29, 2017 to Mar 6, 2018
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History3
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 6, 2018 | FY2018 | P00002 | D | −$36,373.86 | — |
| Oct 20, 2017 | FY2018 | P00001 | D | $0.00 | — |
| Sep 29, 2017 | FY2017 | 0 | — | $126,476.34 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.